{"id":37796,"date":"2026-05-26T15:45:31","date_gmt":"2026-05-26T13:45:31","guid":{"rendered":"https:\/\/www.hollandbio.nl\/?p=37796"},"modified":"2026-06-02T13:19:08","modified_gmt":"2026-06-02T11:19:08","slug":"scaling-beyond-series-c-insights-from-the-frontlines","status":"publish","type":"post","link":"https:\/\/www.hollandbio.nl\/en\/nieuws\/scaling-beyond-series-c-insights-from-the-frontlines\/","title":{"rendered":"Scaling beyond Series C: Insights from the frontlines"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">On Thursday, 21st May, <span style=\"box-sizing: border-box; margin: 0px; padding: 0px;\">hollandbio and De Brauw Blackstone Westbroek collaborated to support biotech companies in\u00a0<em>Scaling Beyond Series C\u00a0<\/em>at<\/span> an exclusive event.\u00a0<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The session kicked off with a market overview by&nbsp;hollandbio\u2019s&nbsp;Annemiek and Jan Christoph Vollgraff (Vice President Healthcare Investment Banking at Van Lanschot Kempen), who set the stage with&nbsp;several&nbsp;observations&nbsp;on developments in the sector:&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>All 10 biotech IPOs in 2026 listed on NASDAQ, with none choosing a European exchange&nbsp;<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Venture capital and private equity firms are facing increasing challenges in raising new funds&nbsp;<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Capital is concentrating around a limited number of late-stage winners&nbsp;<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>This shift raises an important question: what happens if early-stage funding dries up, and the pipeline for future innovation shrinks?&nbsp;<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Jaap Barneveld (Partner at De Brauw Blackstone Westbroek) moderated the panel discussion with Paul van der Horst (CBO at&nbsp;Agomab&nbsp;Therapeutics), Zosia van&nbsp;Eesteren&nbsp;(Senior Associate at Gilde Healthcare), Oscar Marshall (Associate at EQT Group), and Jan Christoph Vollgraff.&nbsp;Raising capital beyond Series C is fundamentally different from earlier stages. The stakes are higher, timelines are longer, and expectations on both sides of the table are significantly more demanding.&nbsp;&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Drawing from&nbsp;Agomab&nbsp;Therapeutics\u2019 journey through Series B to D and its&nbsp;<a href=\"https:\/\/agomab01-a405198c5a-abf8c4eyf4e4gace.z02.azurefd.net\/wp-content\/uploads\/2026\/02\/20260209_Agomab-Announces-Closing-of-Initial-Public-Offering.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">IPO in February 2026<\/a>, Paul van der Horst shared several practical lessons:&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Always explore multiple financing strategies. Think about IPO, private rounds, partnerships, or M&amp;A. Start early,&nbsp;before you can even imagine ever raising a Series C,&nbsp;as each&nbsp;option&nbsp;requires significant preparation time;<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Raise capital when you&nbsp;don\u2019t&nbsp;urgently need it, not when you are under pressure;<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Invest in relationships from day one; trust with investors is built over years, not months;&nbsp;<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Deliver on your promises\u2014credibility compounds over time;<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Professionalize governance, with a focused board and clear operational ownership within the management team;&nbsp;<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Plan financing with a multi-year horizon (typically 2\u20135 years);&nbsp;<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Hire ahead of your future needs, not just current challenges;&nbsp;<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Actively manage your news flow to sustain visibility and engagement.&nbsp;<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">From the investor perspective, Zosia van Eesteren and Oscar Marshall highlighted how expectations are evolving alongside deal sizes:&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>A strong, proven management team is critical;&nbsp;<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Companies with multiple assets and a clear platform strategy are more attractive;&nbsp;<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Experience matters. Serial entrepreneurship is a strong signal;&nbsp;<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Strategic investors, such as pharma partners, strengthen the cap table;&nbsp;<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Non-dilutive funding can be valuable, but&nbsp;the application process&nbsp;should not slow down momentum.&nbsp;<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">While the path to late-stage funding is becoming more complex, one message stood out clearly: preparation is everything. Building the right story, relationships, and strategic options takes years,&nbsp;but only those who are ready can act when the window of opportunity opens.&nbsp;&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Hollandbio would like to&nbsp;sincerely thank&nbsp;De Brauw Blackstone&nbsp;Westbroek&nbsp;for their&nbsp;expertise&nbsp;and hospitality.<\/p>\n\n\n\n<figure class=\"wp-block-gallery has-nested-images columns-default is-cropped wp-block-gallery-1 is-layout-flex wp-block-gallery-is-layout-flex\">\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1030\" height=\"773\" data-id=\"37809\" src=\"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2026\/05\/20260521_160540-1030x773.jpg\" alt=\"\" class=\"wp-image-37809\" srcset=\"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2026\/05\/20260521_160540-1030x773.jpg 1030w, https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2026\/05\/20260521_160540-300x225.jpg 300w, https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2026\/05\/20260521_160540-768x576.jpg 768w, https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2026\/05\/20260521_160540-1536x1152.jpg 1536w, https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2026\/05\/20260521_160540-2048x1536.jpg 2048w, https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2026\/05\/20260521_160540-1500x1125.jpg 1500w, https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2026\/05\/20260521_160540-705x529.jpg 705w\" sizes=\"(max-width: 1030px) 100vw, 1030px\" \/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1030\" height=\"773\" data-id=\"37837\" src=\"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2026\/05\/20260521_162505-1030x773.jpg\" alt=\"\" class=\"wp-image-37837\" srcset=\"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2026\/05\/20260521_162505-1030x773.jpg 1030w, https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2026\/05\/20260521_162505-300x225.jpg 300w, https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2026\/05\/20260521_162505-768x576.jpg 768w, https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2026\/05\/20260521_162505-1536x1152.jpg 1536w, https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2026\/05\/20260521_162505-2048x1536.jpg 2048w, https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2026\/05\/20260521_162505-1500x1125.jpg 1500w, https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2026\/05\/20260521_162505-705x529.jpg 705w\" sizes=\"(max-width: 1030px) 100vw, 1030px\" \/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"773\" height=\"1030\" data-id=\"37804\" src=\"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2026\/05\/20260521_171809-773x1030.jpg\" alt=\"\" class=\"wp-image-37804\" srcset=\"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2026\/05\/20260521_171809-773x1030.jpg 773w, https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2026\/05\/20260521_171809-225x300.jpg 225w, https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2026\/05\/20260521_171809-768x1024.jpg 768w, https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2026\/05\/20260521_171809-1152x1536.jpg 1152w, https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2026\/05\/20260521_171809-1536x2048.jpg 1536w, https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2026\/05\/20260521_171809-1125x1500.jpg 1125w, https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2026\/05\/20260521_171809-529x705.jpg 529w, https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2026\/05\/20260521_171809.jpg 1920w\" sizes=\"(max-width: 773px) 100vw, 773px\" \/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1030\" height=\"773\" data-id=\"37849\" src=\"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2026\/05\/20260521_164638-1030x773.jpg\" alt=\"\" class=\"wp-image-37849\" srcset=\"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2026\/05\/20260521_164638-1030x773.jpg 1030w, https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2026\/05\/20260521_164638-300x225.jpg 300w, https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2026\/05\/20260521_164638-768x576.jpg 768w, https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2026\/05\/20260521_164638-1536x1152.jpg 1536w, https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2026\/05\/20260521_164638-2048x1536.jpg 2048w, https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2026\/05\/20260521_164638-1500x1125.jpg 1500w, https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2026\/05\/20260521_164638-705x529.jpg 705w\" sizes=\"(max-width: 1030px) 100vw, 1030px\" \/><\/figure>\n<\/figure>\n","protected":false},"excerpt":{"rendered":"<p>On Thursday, 21st May, hollandbio and De Brauw Blackstone Westbroek collaborated to support biotech companies in\u00a0Scaling Beyond Series C\u00a0at an exclusive event.\u00a0 The session kicked off with a market overview by&nbsp;hollandbio\u2019s&nbsp;Annemiek and Jan Christoph Vollgraff (Vice President Healthcare Investment Banking at Van Lanschot Kempen), who set the stage with&nbsp;several&nbsp;observations&nbsp;on developments in the sector:&nbsp; Jaap Barneveld [&hellip;]<\/p>\n","protected":false},"author":24,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[57,1,43,45],"tags":[],"class_list":["post-37796","post","type-post","status-publish","format-standard","hentry","category-ijzersterk-innovatieklimaat","category-niet-gecategoriseerd","category-innovatieklimaat","category-uitgelicht"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Scaling beyond Series C: Insights from the frontlines - hollandbio<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.hollandbio.nl\/en\/nieuws\/scaling-beyond-series-c-insights-from-the-frontlines\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Scaling beyond Series C: Insights from the frontlines - hollandbio\" \/>\n<meta property=\"og:description\" content=\"On Thursday, 21st May, hollandbio and De Brauw Blackstone Westbroek collaborated to support biotech companies in\u00a0Scaling Beyond Series C\u00a0at an exclusive event.\u00a0 The session kicked off with a market overview by&nbsp;hollandbio\u2019s&nbsp;Annemiek and Jan Christoph Vollgraff (Vice President Healthcare Investment Banking at Van Lanschot Kempen), who set the stage with&nbsp;several&nbsp;observations&nbsp;on developments in the sector:&nbsp; Jaap Barneveld [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.hollandbio.nl\/en\/nieuws\/scaling-beyond-series-c-insights-from-the-frontlines\/\" \/>\n<meta property=\"og:site_name\" content=\"hollandbio\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-26T13:45:31+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-02T11:19:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2026\/05\/20260521_160540.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1920\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Idalia Dlugosz\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@hollandbio\" \/>\n<meta name=\"twitter:site\" content=\"@hollandbio\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Idalia Dlugosz\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/scaling-beyond-series-c-insights-from-the-frontlines\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/scaling-beyond-series-c-insights-from-the-frontlines\\\/\"},\"author\":{\"name\":\"Idalia Dlugosz\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/person\\\/20e3aa22ca991fdb93f4c843c0c0099c\"},\"headline\":\"Scaling beyond Series C: Insights from the frontlines\",\"datePublished\":\"2026-05-26T13:45:31+00:00\",\"dateModified\":\"2026-06-02T11:19:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/scaling-beyond-series-c-insights-from-the-frontlines\\\/\"},\"wordCount\":507,\"publisher\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/scaling-beyond-series-c-insights-from-the-frontlines\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.hollandbio.nl\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/20260521_160540-1030x773.jpg\",\"articleSection\":[\"IJzersterk innovatieklimaat\",\"Niet-gecategoriseerd\",\"Innovatieklimaat\",\"Uitgelicht\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/scaling-beyond-series-c-insights-from-the-frontlines\\\/\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/scaling-beyond-series-c-insights-from-the-frontlines\\\/\",\"name\":\"Scaling beyond Series C: Insights from the frontlines - hollandbio\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/scaling-beyond-series-c-insights-from-the-frontlines\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/scaling-beyond-series-c-insights-from-the-frontlines\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.hollandbio.nl\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/20260521_160540-1030x773.jpg\",\"datePublished\":\"2026-05-26T13:45:31+00:00\",\"dateModified\":\"2026-06-02T11:19:08+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/scaling-beyond-series-c-insights-from-the-frontlines\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/scaling-beyond-series-c-insights-from-the-frontlines\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/scaling-beyond-series-c-insights-from-the-frontlines\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/20260521_160540-1030x773.jpg\",\"contentUrl\":\"https:\\\/\\\/www.hollandbio.nl\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/20260521_160540-1030x773.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/scaling-beyond-series-c-insights-from-the-frontlines\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Scaling beyond Series C: Insights from the frontlines\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\",\"name\":\"hollandbio\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\",\"name\":\"hollandbio\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/HollandBIO_logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.hollandbio.nl\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/HollandBIO_logo.svg\",\"width\":218.664,\"height\":29.659,\"caption\":\"hollandbio\"},\"image\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/hollandbio\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/hollandbio\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/person\\\/20e3aa22ca991fdb93f4c843c0c0099c\",\"name\":\"Idalia Dlugosz\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Scaling beyond Series C: Insights from the frontlines - hollandbio","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.hollandbio.nl\/en\/nieuws\/scaling-beyond-series-c-insights-from-the-frontlines\/","og_locale":"en_US","og_type":"article","og_title":"Scaling beyond Series C: Insights from the frontlines - hollandbio","og_description":"On Thursday, 21st May, hollandbio and De Brauw Blackstone Westbroek collaborated to support biotech companies in\u00a0Scaling Beyond Series C\u00a0at an exclusive event.\u00a0 The session kicked off with a market overview by&nbsp;hollandbio\u2019s&nbsp;Annemiek and Jan Christoph Vollgraff (Vice President Healthcare Investment Banking at Van Lanschot Kempen), who set the stage with&nbsp;several&nbsp;observations&nbsp;on developments in the sector:&nbsp; Jaap Barneveld [&hellip;]","og_url":"https:\/\/www.hollandbio.nl\/en\/nieuws\/scaling-beyond-series-c-insights-from-the-frontlines\/","og_site_name":"hollandbio","article_published_time":"2026-05-26T13:45:31+00:00","article_modified_time":"2026-06-02T11:19:08+00:00","og_image":[{"width":2560,"height":1920,"url":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2026\/05\/20260521_160540.jpg","type":"image\/jpeg"}],"author":"Idalia Dlugosz","twitter_card":"summary_large_image","twitter_creator":"@hollandbio","twitter_site":"@hollandbio","twitter_misc":{"Written by":"Idalia Dlugosz","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/scaling-beyond-series-c-insights-from-the-frontlines\/#article","isPartOf":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/scaling-beyond-series-c-insights-from-the-frontlines\/"},"author":{"name":"Idalia Dlugosz","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/person\/20e3aa22ca991fdb93f4c843c0c0099c"},"headline":"Scaling beyond Series C: Insights from the frontlines","datePublished":"2026-05-26T13:45:31+00:00","dateModified":"2026-06-02T11:19:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/scaling-beyond-series-c-insights-from-the-frontlines\/"},"wordCount":507,"publisher":{"@id":"https:\/\/www.hollandbio.nl\/en\/#organization"},"image":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/scaling-beyond-series-c-insights-from-the-frontlines\/#primaryimage"},"thumbnailUrl":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2026\/05\/20260521_160540-1030x773.jpg","articleSection":["IJzersterk innovatieklimaat","Niet-gecategoriseerd","Innovatieklimaat","Uitgelicht"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/scaling-beyond-series-c-insights-from-the-frontlines\/","url":"https:\/\/www.hollandbio.nl\/en\/nieuws\/scaling-beyond-series-c-insights-from-the-frontlines\/","name":"Scaling beyond Series C: Insights from the frontlines - hollandbio","isPartOf":{"@id":"https:\/\/www.hollandbio.nl\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/scaling-beyond-series-c-insights-from-the-frontlines\/#primaryimage"},"image":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/scaling-beyond-series-c-insights-from-the-frontlines\/#primaryimage"},"thumbnailUrl":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2026\/05\/20260521_160540-1030x773.jpg","datePublished":"2026-05-26T13:45:31+00:00","dateModified":"2026-06-02T11:19:08+00:00","breadcrumb":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/scaling-beyond-series-c-insights-from-the-frontlines\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.hollandbio.nl\/en\/nieuws\/scaling-beyond-series-c-insights-from-the-frontlines\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/scaling-beyond-series-c-insights-from-the-frontlines\/#primaryimage","url":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2026\/05\/20260521_160540-1030x773.jpg","contentUrl":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2026\/05\/20260521_160540-1030x773.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/scaling-beyond-series-c-insights-from-the-frontlines\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.hollandbio.nl\/en\/"},{"@type":"ListItem","position":2,"name":"Scaling beyond Series C: Insights from the frontlines"}]},{"@type":"WebSite","@id":"https:\/\/www.hollandbio.nl\/en\/#website","url":"https:\/\/www.hollandbio.nl\/en\/","name":"hollandbio","description":"","publisher":{"@id":"https:\/\/www.hollandbio.nl\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.hollandbio.nl\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.hollandbio.nl\/en\/#organization","name":"hollandbio","url":"https:\/\/www.hollandbio.nl\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2023\/08\/HollandBIO_logo.svg","contentUrl":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2023\/08\/HollandBIO_logo.svg","width":218.664,"height":29.659,"caption":"hollandbio"},"image":{"@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/hollandbio","https:\/\/www.linkedin.com\/company\/hollandbio\/"]},{"@type":"Person","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/person\/20e3aa22ca991fdb93f4c843c0c0099c","name":"Idalia Dlugosz"}]}},"_links":{"self":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts\/37796","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/comments?post=37796"}],"version-history":[{"count":2,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts\/37796\/revisions"}],"predecessor-version":[{"id":37860,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts\/37796\/revisions\/37860"}],"wp:attachment":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/media?parent=37796"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/categories?post=37796"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/tags?post=37796"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}